Alpha-1 Antitrypsin Dynamics in COVID-19 Pathophysiology
Summary
Alpha-1 antitrypsin (AAT) is a circulating serine protease inhibitor central to lung protection and the regulation of inflammatory responses. In COVID-19, dysregulation of AAT levels and activity influences viral entry, pulmonary inflammation and tissue injury. Adequate AAT concentrations limit the proteolytic activation of viral spike proteins and temper neutrophil elastase-driven damage, while deficiency or functional impairment of AAT is linked to heightened disease severity and adverse outcomes. Beyond its antiprotease function, AAT acts as an acute-phase protein that modulates cytokine release and coagulation pathways. Understanding the interplay between host proteases and AAT underpins potential host-directed therapies aimed at restoring protease–anti-protease balance and alleviating both viral propagation and immunopathology.
Research from Nature Portfolio
Recent studies have demonstrated that physiological concentrations of AAT bind to and inhibit the transmembrane serine protease TMPRSS2, thereby suppressing SARS-CoV-2 spike priming and viral entry into human airway epithelial cells. This innate mechanism suggests repurposing AAT-rich formulations as an adjunctive antiviral strategy. Further work has shown that low-molecular-weight heparins, such as enoxaparin, enhance AAT’s inhibitory potency by stabilising the AAT–TMPRSS2 interface through electrostatic bridging. This combination not only reduces coronavirus infection rates in primary epithelial cultures but also carries inherent anti-inflammatory benefits. Such host-directed approaches remain robust against viral mutations and offer dual antiviral and immunomodulatory effects.
Alpha-1 Antitrypsin Dynamics in COVID-19 Pathophysiology publication trend
The graph below shows the total number of articles in alpha-1 antitrypsin dynamics in covid-19 pathophysiology across all publications each year (not limited to Nature Index journals).
Technical terms
Alpha-1 antitrypsin (AAT): A glycoprotein serine protease inhibitor that protects tissues from enzyme-mediated damage and modulates inflammatory processes.
Serpin: A family of proteins that inhibit serine proteases through a conformational “suicide” mechanism, preventing excessive proteolysis.
TMPRSS2: A host transmembrane serine protease responsible for priming viral spike proteins to facilitate SARS-CoV-2 entry into host cells.
Protease–anti-protease imbalance: A state in which proteolytic enzyme activity exceeds the capacity of endogenous inhibitors, leading to tissue injury.
Acute-phase protein: A plasma protein whose concentration changes significantly in response to inflammation, reflecting innate immune activation.
References
- Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence. Biochemical Society Transactions (2023).
- Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study. Biomedicines (2023).
- Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications. EBioMedicine (2022).
- Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nature Communications (2021).
- Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19. Scientific Reports (2022).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.